Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
Amgen Foundation
Awards and Accolades
Therapy Areas
Cardiovascular Metabolic
Bone Health
Inflammation
Oncology
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research & Development Strategy
Overview
Human & Disease Biology
Novel Targets & Modalities
Clinical Trial Optimization
AI & Data Science
Pipeline
Amgen Science Podcasts
Scientific Advisory Boards
Biosimilars
Clinical Trials
Overview
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2024 Sustainability Highlights Report
Environment, Social and Governance Strategy
Healthy People
Overview
Access to Healthcare
Health Equity
Healthy Society
Overview
Diversity, Inclusion and Belonging
Human Capital Management
Community Investment and Amgen Foundation
Supplier Diversity
Healthy Planet
Overview
Environmental Sustainability
Supplier Sustainability
Healthy Amgen
Overview
Corporate Governance
Business Ethics and Compliance
Ethical Research and Development
Patient Safety
Product Quality
Cybersecurity and Data Privacy
Reporting and Metrics
Overview
CDP
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Newsroom
Partners
Investors
Careers
Amgen Worldwide
Overview
Amgen History
Mission and Values
Leadership
Amgen Foundation <i class="fa fa-external-link"></i>
Awards and Accolades
Therapy Areas
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
About
Overview
Amgen History
Mission and Values
Leadership
Amgen Foundation
Therapy Areas
General Medicine
Rare Disease
Inflammation
Oncology
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research & Development Strategy
Human & Disease Biology
Novel Targets & Modalities
Clinical Trial Optimization
AI in Research & Development
Pipeline
Amgen Science Podcasts
Scientific Advisory Boards
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
Scientific Community Initiatives
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2024 Sustainability Highlights Report
Corporate Sustainability Strategy
Healthy People
Access to Healthcare
Health Equity
Healthy Society
Amgen Foundation and Community Investment
Diversity, Inclusion and Belonging
Human Capital Management
Supplier Diversity
Healthy Planet
Environmental Sustainability
Supplier Sustainability
Healthy Amgen
Corporate Governance
Business Ethics and Compliance
Ethical Research and Development
Patient Safety
Product Quality
Cybersecurity and Data Privacy
Reporting and Metrics
CDP
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Newsroom
Partners
Investors
Careers
X
Home
>
About
>
How We Operate
>
Policies, Practices and Disclosures
>
Transparency Disclosures
>
Donation and Grant Recipients
>
Amgen Foundation Grants
>
How We Operate
Amgen Foundation Grants
Select a Report
2025 Q2 Report
2025 Q1 Report
2024 Q4 Report
2024 Q3 Report
2024 Q2 Report
2024 Q1 Report
2023 Q4 Report
2023 Q3 Report
2023 Q2 Report
2023 Q1 Report
2022 Q4 Report
2022 Q3 Report
2022 Q2 Report
2022 Q1 Report
2021 Q4 Report
2021 Q3 Report
2021 Q2 Report
2021 Q1 Report
2020 Q4 Report
2020 Q3 Report
2020 Q2 Report
2020 Q1 Report
2019 Q4 Report
2019 Q3 Report
2019 Q2 Report
2019 Q1 Report
2018 Q4 Report
2018 Q3 Report
2018 Q2 Report
2018 Q1 Report
2017 Q4 Report
2017 Q3 Report
2017 Q2 Report
2017 Q1 Report
2016 Q4 Report
2016 Q3 Report
2016 Q2 Report
2016 Q1 Report
2015 Q4 Report
2015 Q3 Report
2015 Q2 Report
2015 Q1 Report
2014 Q4 Report
2014 Q3 Report
2014 Q2 Report
2014 Q1 Report
2013 Q4 Report
2013 Q3 Report
2013 Q2 Report
2013 Q1 Report
2012 Q4 Report
2012 Q3 Report
2012 Q2 Report
2012 Q1 Report
2011 Q4 Report
2011 Q3 Report
2011 Q2 Report
2011 Q1 Report
2010 Q4 Report
2010 Q3 Report
2010 Q2 Report
2010 Q1 Report
2009 Q4 Report
2009 Q3 Report
2009 Q2 Report
2009 Q1 Report
2008 Q4 Report
2008 Q3 Report
2008 Q2 Report
2008 Q1 Report
Grants
Paid To Name
Program Name
Individual Payment Amount
Donation and Grant Recipients
Independent Medical Education and Healthcare Donations
Amgen Foundation Grants
Amgen Funding to European Patient Organizations
Donations & Grant Disclosures FAQs
